Non-Invasive Body Contouring Patents: Who Leads, Trends 2026
Non-Invasive Body Contouring Patents: Mapping the Field
Concentrated at the top. The five leading assignees hold 196 of 279 records in scope (70.3%), and the top ten hold 87.1% — a field with little room left for a new entrant to build a broad position. Filings peaked at 30 in 2019, held in the low-to-mid teens through the early 2020s, and reached 14 in 2024 — up 27% from 11 in 2021. The 2025-2026 figures (down to 5 in the partial latest year) reflect publication lag of roughly 18 months rather than a real slowdown in filing.
- 1ZELTIQ AESTHETICS INC86
- 2BTL MEDICAL SOLUTIONS AS63
- 3DASYO TECH LTD20
- 4THE GENERAL HOSPITAL CORP16
- 5CYNOSURE INC11
See the full non-invasive body contouring analysis in Eureka
- The complete ranking, not just the top five
- Every IPC branch with its share of the corpus
- The most-cited records, and where claim space is still thin
Common questions on this landscape
Who holds the most patents in non-invasive body contouring?
One assignee leads the field with 86 of the 279 records in scope, well ahead of the fifth-ranked assignee at 11 and the tenth-ranked at 8. The top five assignees together hold 196 records, or 70.3% of the total, and the top ten hold 87.1%. This means the field is dominated by a small number of large portfolios rather than being evenly spread, so any competitive or freedom-to-operate review should start with the leader’s filings specifically.
Is filing activity in body contouring devices still growing?
Yes, based on the most recent complete data: filings rose from 11 in 2021 to 14 in 2024, a 27% increase over that span. The historical peak was higher, at 30 filings in 2019, so growth has not returned to that level, but the trend from 2021 to 2024 is upward, not flat. The lower counts shown for 2025 and 2026 reflect the roughly 18-month lag between filing and publication and should not be read as declining interest.
What technology areas do these patents actually cover?
The claims cluster heavily around three IPC subclasses: A61F (implants and prostheses) at 49.8% of the 279 records, A61N (electrotherapy and radiation therapy) at 45.2%, and A61B (diagnosis and surgery) at 44.1%. Because a single patent can carry multiple IPC classes, these figures overlap substantially — a typical filing claims a physical applicator structure, an energy-delivery mechanism, and a procedural or diagnostic step together. Smaller shares of records touch A61K medicinal preparations, A61H physical therapy, A61P therapeutic activity, A61Q cosmetics use, and A61M body-fluid devices.
Disclaimer. This analysis is based on Patsnap Eureka data drawn from a limited snapshot of global patent records and is provided for general information and reference only. Patent data carries inherent limitations — recent filings are under-counted because of publication lag, counts may be on a record or family basis, classification and applicant-name data may contain errors or duplicates, and the underlying search query defines the scope shown — so the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing here is an exhaustive prior-art, novelty, freedom-to-operate or validity search, nor does it constitute legal, financial or professional advice, and it should not be relied upon as such. Verify independently and review with qualified patent and legal professionals before acting on it.
Method: Filing trend and technology composition. Derived from a Patsnap search on Non-Invasive Body Contouring covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish. Every share divides by all records in scope. Data: Patsnap Eureka. See the full landscape report.